Cite
Tocilizumab is effective in a familial Mediterranean fever patient complicated with histologically proven recurrent fasciitis and myositis.
MLA
Umeda, Masataka, et al. “Tocilizumab Is Effective in a Familial Mediterranean Fever Patient Complicated with Histologically Proven Recurrent Fasciitis and Myositis.” International Journal of Rheumatic Diseases, vol. 20, no. 11, Nov. 2017, pp. 1868–71. EBSCOhost, https://doi.org/10.1111/1756-185X.12776.
APA
Umeda, M., Aramaki, T., Fujikawa, K., Iwamoto, N., Ichinose, K., Terada, K., Takeo, G., Yonemitsu, N., Ueki, Y., Migita, K., & Kawakami, A. (2017). Tocilizumab is effective in a familial Mediterranean fever patient complicated with histologically proven recurrent fasciitis and myositis. International Journal of Rheumatic Diseases, 20(11), 1868–1871. https://doi.org/10.1111/1756-185X.12776
Chicago
Umeda, Masataka, Toshiyuki Aramaki, Keita Fujikawa, Naoki Iwamoto, Kunihiro Ichinose, Kaoru Terada, Gou Takeo, et al. 2017. “Tocilizumab Is Effective in a Familial Mediterranean Fever Patient Complicated with Histologically Proven Recurrent Fasciitis and Myositis.” International Journal of Rheumatic Diseases 20 (11): 1868–71. doi:10.1111/1756-185X.12776.